Imunon, Inc. Warrants and Rights Outstanding
Imunon, Inc. (IMNN) had Warrants and Rights Outstanding of $398.04 thousand as of 2014-09-30, per its 10-Q filed 2014-11-10.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2014-11-10
- 2014-09-30: Warrants and Rights Outstanding $398.04K.
- 2014-06-30: Warrants and Rights Outstanding $476.26K.
- 2014-06-09: Warrants and Rights Outstanding $97.49K.
- 2014-03-31: Warrants and Rights Outstanding $0.00.
| Period end | Warrants and Rights Outstanding | Warrants and Rights Outstanding as first filed |
|---|---|---|
| 2014-09-30 | $398.04K 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $476.26K 10-Q · filed 2014-08-07 | |
| 2014-06-09 | $97.49K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $3.03K 10-Q · filed 2014-11-10 | $3.27T 10-K · filed 2014-03-13 |
| 2013-03-31 | $5.40M 10-Q · filed 2013-08-08 | |
| 2013-02-26 | $5.40M 10-Q · filed 2014-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |